According to Rohto Pharmaceutical's latest financial reports the company has $0.58 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.60 B | 0.62% |
2022-03-31 | $0.59 B | 24.24% |
2021-03-31 | $0.48 B | 14.49% |
2020-03-31 | $0.41 B | 22.96% |
2019-03-31 | $0.34 B | 18.76% |
2018-03-31 | $0.28 B | 34.18% |
2017-03-31 | $0.21 B | 4.24% |
2016-03-31 | $0.20 B | -4.23% |
2015-03-31 | $0.21 B | -4.2% |
2014-03-31 | $0.22 B | 6.21% |
2013-03-31 | $0.21 B | 13.54% |
2012-03-31 | $0.18 B | 9.37% |
2011-03-31 | $0.16 B | 18.68% |
2010-03-31 | $0.14 B | 130.08% |
2009-03-31 | $62.15 M | -36.87% |
2008-03-31 | $98.44 M |